✦ LIBER ✦

Efficacy of Desmopressin and Enuretic Alarm as the First and Second-Line Treatment for Monosymptomatic Nocturnal Enuresis; A Prospective, Randomized, Cross-Over Study

✍ Scribed by Young-Suk Lee; Kwan Hyun Park; Minki Baek

Book ID: 116694006
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 38 KB
Volume: 6
Category: Article
ISSN: 1477-5131
DOI: 10.1016/j.jpurol.2010.02.114

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

877 EFFICACY OF DESMOPRESSIN AND ENURETI

877 EFFICACY OF DESMOPRESSIN AND ENURETIC ALARM AS THE FIRST AND SECOND-LINE TREATMENT FOR MONOSYMPTOMATIC NOCTURNAL ENURESIS; A PROSPECTIVE, RANDOMIZED, CROSSOVER STUDY

✍ T.H. Kim; Y. Lee; J.H. Choe; K.H. Park 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Efficacy of Desmopressin and Enuresis Al

Efficacy of Desmopressin and Enuresis Alarm as First and Second Line Treatment for Primary Monosymptomatic Nocturnal Enuresis: Prospective Randomized Crossover Study

✍ Kwak, Kyung Won; Lee, Young-Suk; Park, Kwan Hyun; Baek, Minki 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 756 KB

Desmopressin alone versus desmopressin a

Desmopressin alone versus desmopressin and an anticholinergic in the first-line treatment of primary monosymptomatic nocturnal enuresis: a multicenter study

✍ Park, Se Jin; Park, Ji Min; Pai, Ki Soo; Ha, Tae Sun; Lee, Sang Don; Baek, Minki 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 164 KB

Response to Desmopressin as a Function o

Response to Desmopressin as a Function of Urine Osmolality in the Treatment of Monosymptomatic Nocturnal Enuresis: A Double-Blind Prospective Study

✍ Rushton, H. Gil*; Belman, A. Barry; Zaontz, Mark; Skoog, Steven J.; Sihelnik, St 📂 Article 📅 1995 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 569 KB

Capecitabine plus paclitaxel versus epir

Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group

✍ Hans-Joachim Lück, Andreas Du Bois, Sibylle Loibl, Iris Schrader, Jens Huober, V 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 279 KB

Anastrozole (‘Arimidex’) versus tamoxife

Anastrozole (‘Arimidex’) versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: Results of the double-blind cross-over SAKK trial 21/95 - a sub-study of the TARGET (Tamoxifen or ‘Arimidex’ Randomized Group Efficacy and Tolerability) trial

✍ Beat Thürlimann; Dagmar Hess; Dieter Köberle; Isabella Senn; Pierluigi Ballabeni 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 348 KB